39863 |
Multidisciplinary Sciences |
EGR1 as a potential marker of prognosis in extranodal NK/T-cell lymphoma |
SCI REP-UK 2021 10.1038/s41598-021-89754-8 |
김원석 |
2021 |
39862 |
Oncology; Hematology |
Daratumumab monotherapy for patients with relapsed or refractory natur... |
J HEMATOL ONCOL 2021 10.1186/s13045-020-01020-y |
김원석 |
2021 |
39861 |
Oncology; Hematology |
Comprehensive analysis of clinical, pathological, and genomic characte... |
EXP HEMATOL ONCOL 2021 10.1186/s40164-021-00224-3 |
김원석 |
2021 |
39860 |
Hematology |
Zanubrutinib for the treatment of relapsed or refractory mantle cell l... |
BLOOD ADV 2021 10.1182/bloodadvances.2020004074 |
김원석 |
2021 |
39859 |
Oncology |
The mutation of BCOR is highly recurrent and oncogenic in mature T-cel... |
BMC CANCER 2021 10.1186/s12885-021-07806-8 |
김원석 |
2021 |
39858 |
Multidisciplinary Sciences |
Role in staging and prognostic value of pretherapeutic F-18 FDG PET/CT... |
SCI REP-UK 2021 10.1038/s41598-021-88815-2 |
김원석 |
2021 |
39857 |
Oncology |
Real-World, Single-Center Data for Lenalidomide Plus Rituximab in Rela... |
CANCER MANAG RES 2021 10.2147/CMAR.S309092 |
김원석 |
2021 |
39856 |
Medicine, General & Internal |
Real-world data on the survival outcome of patients with newly diagnos... |
KOREAN J INTERN MED 2021 10.3904/kjim.2019.367 |
김원석 |
2021 |
39855 |
Oncology |
Phase I studies of darinaparsin in patients with relapsed or refractor... |
JPN J CLIN ONCOL 2021 10.1093/jjco/hyaa177 |
김원석 |
2021 |
39854 |
Oncology |
Impact of transformation on the survival of patients diagnosed with fo... |
J CANCER 2021 10.7150/jca.54434 |
김원석 |
2021 |